Clinical-Stage Platforms
Part of Biotech - Drug Development
 TMO | Thermo Fisher Scientific, Inc. | $183.0b | $509.73 | +1.4% | 2.9M |
 A | Agilent Technologies Inc. | $38.2b | $134.42 | +0.4% | 1.6M |
 WAT | Waters Corp | $37.7b | $374.51 | -0.7% | 795.5K |
 IQV | IQVIA Holdings Inc. | $30.4b | $189.16 | +2.5% | 1.0M |
 RPRX | Royalty Pharma plc Class A Ordinary Shares | $24.7b | $55.59 | +2.9% | 4.4M |
 WST | West Pharmaceutical Services, Inc. | $22.8b | $350.73 | +1.2% | 672.2K |
 ASND | Ascendis Pharma A/S Ordinary Share | $13.8b | $261.05 | -0.2% | 922.2K |
 MEDP | Medpace Holdings, Inc. Common Stock | $12.8b | $523.40 | +1.2% | 264.1K |
 RVTY | Revvity, Inc. | $11.7b | $113.03 | -0.4% | 2.4M |
 ICLR | Icon Plc | $10.4b | $169.94 | +5.6% | 1.2M |
 BRKR | Bruker Corporation | $9.0b | $61.00 | +0.1% | 1.4M |
 CRL | Charles River Laboratories International, Inc. | $8.7b | $213.05 | +1.4% | 1.0M |
 BIO.B | Bio-Rad Laboratories, Inc. Class B | $8.1b | $299.40 | 0.0% | 11 |
 TECH | Bio-Techne Corp. | $8.1b | $70.42 | +0.4% | 10.2M |
 HALO | Halozyme Therapeutics, Inc. | $7.9b | $75.08 | +3.2% | 1.7M |
 QGEN | QIAGEN N.V. | $7.5b | $39.00 | +1.2% | 2.7M |
 RGEN | Repligen Corp | $7.0b | $148.01 | +1.2% | 1.3M |
 KYMR | Kymera Therapeutics, Inc. Common Stock | $6.7b | $108.20 | -7.5% | 2.1M |
 CELC | Celcuity Inc. Common Stock | $6.5b | $99.14 | +4.2% | 1.2M |
 AVTR | Avantor, Inc. | $6.2b | $10.34 | +2.0% | 7.3M |
 CGON | CG Oncology, Inc. Common stock | $5.5b | $72.01 | -1.3% | 1.4M |
 LGND | Ligand Pharmaceuticals Inc. | $4.6b | $284.00 | +2.6% | 448.3K |
 MANE | Veradermics, Incorporated | $4.2b | $122.95 | +6.3% | 1.2M |
 TWST | Twist Bioscience Corporation Common Stock | $4.2b | $98.00 | +3.3% | 2.7M |
 OGN | Organon & Co. | $3.5b | $13.51 | +0.2% | 1.8M |
 RLAY | Relay Therapeutics, Inc. Common Stock | $3.1b | $18.67 | +3.9% | 4.0M |
 KOD | Kodiak Sciences Inc Common Stock | $2.3b | $35.87 | +5.4% | 909.8K |
 DAWN | Day One Biopharmaceuticals, Inc. Common Stock | $2.2b | $21.52 | -0.0% | 3.0M |
 TRVI | Trevi Therapeutics, Inc. Common Stock | $2.0b | $18.51 | +0.6% | 2.7M |
 TYRA | Tyra Biosciences, Inc. Common Stock | $2.0b | $31.91 | +3.0% | 1.3M |
 RXRX | Recursion Pharmaceuticals, Inc. Class A Common Stock | $1.9b | $3.51 | +5.1% | 20.6M |
 ABCL | AbCellera Biologics Inc. Common Shares | $1.9b | $7.40 | +10.7% | 13.6M |
 ZYME | Zymeworks Inc. | $1.8b | $24.42 | +1.6% | 390.1K |
 NRIX | Nurix Therapeutics, Inc. Common stock | $1.8b | $22.35 | +2.0% | 2.9M |
 SLS | SELLAS Life Sciences Group, Inc. Common Stock | $1.7b | $12.21 | +17.7% | 15.4M |
 GENB | Generate Biomedicines, Inc. Common Stock | $1.7b | $16.80 | +0.7% | 1.2M |
 GLUE | Monte Rosa Therapeutics, Inc. Common Stock | $1.7b | $22.23 | +2.9% | 1.6M |
 INBX | Inhibrx Biosciences, Inc. Common Stock | $1.5b | $94.73 | -0.9% | 289.0K |
 FTRE | Fortrea Holdings Inc. Common Stock | $1.5b | $17.66 | -0.3% | 1.4M |
 BCAX | Bicara Therapeutics Inc. Common Stock | $1.4b | $26.85 | +2.1% | 1.5M |
 HROW | Harrow, Inc. Common Stock | $1.3b | $41.62 | +1.4% | 888.7K |
 SDGR | Schrodinger, Inc. Common Stock | $1.1b | $17.24 | +4.2% | 2.3M |
 OPK | Opko Health Inc. | $1.1b | $1.55 | +0.7% | 3.8M |
 ABSI | Absci Corporation Common Stock | $1.1b | $10.97 | +6.6% | 10.3M |
 ALVO | Alvotech Ordinary Shares | $1.0b | $3.68 | +6.0% | 942.0K |
 SANA | Sana Biotechnology, Inc. Common Stock | $0.9b | $3.44 | +4.6% | 3.1M |
 PCRX | Pacira BioSciences, Inc. Common Stock | $0.9b | $25.25 | +3.4% | 502.5K |
 CERT | Certara, Inc. Common Stock | $0.9b | $5.83 | +5.6% | 2.9M |
 VOR | Vor Biopharma Inc. Common Stock | $0.8b | $15.55 | +8.6% | 1.9M |
 PHAT | Phathom Pharmaceuticals, Inc. Common Stock | $0.8b | $10.81 | +3.4% | 1.3M |